Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
64,260,954
-
Share change
-
+5,378,481
-
Total reported value
-
$853,996,750
-
Price per share
-
$13.29
-
Number of holders
-
130
-
Value change
-
+$79,413,578
-
Number of buys
-
103
-
Number of sells
-
32
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q1 2019
As of 31 Mar 2019,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,260,954 shares.
The largest 10 holders included
Levin Easterly Partners LLC, PRIMECAP MANAGEMENT CO/CA/, Russell Investments Group, Ltd., Neuberger Berman Group LLC, BlackRock Inc., DRIEHAUS CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, RTW INVESTMENTS, LP, and FMR LLC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.